Common Equity: The sum of all common equity items.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) had Common Equity of $12.77B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$10.74B |
|
$3.03B |
|
$4.70B |
|
$15.43B |
|
$2.47B |
|
-- |
|
$189.40M |
|
$2.66B |
|
|
Common Equity |
$12.77B |
$12.40B |
|
$12.77B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$1.57B |
|
$-227.11M |
|
$-1.58B |
|
$2.69B |
|
$2.46B |
|
$-227.83M |
|
-- |
|
$-1.52B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|